Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

How AI is Transforming Clinical Trials
AI is already reshaping the clinical trials industry and that transformation looks set to continue over the next five years. New technologies will enable the development of more personalized medicines, empower more responsive trial designs and improve informed decision making by unlocking new data insights. read more
AI in Pharmacovigilance: Key Takeaways from Boehringer Ingelheim’s Recent Rollout
In conversation with Pharmaceutical Outsourcing, Claudia Lehman, Head of Global Pharmacovigilance Operations at Boehringer Ingelheim and Lucinda Smith, ArisGlobal’s Chief Safety Product Officer, reflect on some of the lessons learned from Boehringer’s deployment of AI to date in targeted use cases, starting with adverse event case intake and processing. read more
Engaging with Regulators for Single-Arm Oncology Research Trials
When well-planned and well-executed, single-arm trials can accelerate access to life-saving therapies that might otherwise never reach desperate cancer patients. read more
Executive Q&A - A Strategic Acquisition: Insights and Ideas
An interview with Brian Morrissey, General Manager of Gaelic Laboratories, which has acquired Athlone Laboratories in a strategic deal that typifies the current pharma M&A landscape and puts all of Ireland’s Beta-Lactam manufacturing capacity under one ownership umbrella. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Fujifilm Announces Leadership Changes to Enhance Life Sciences Capabilities
Monday, June 08, 2026
FUJIFILM Holdings America Corporation announced additional leadership responsibilities for three key leaders in its Life Sciences Group companies. read more
WuXi Biologics Singapore CRDMO Hub Completes Modular Topping-Out of Drug Product Facility
Monday, June 08, 2026
WuXi Biologics announced that it has completed the topping out of the Drug Product (DP) facility at its Singapore CRDMO Hub. read more
Made Scientific and Pluristyx Launch Integrated iPSC Development & Manufacturing Partnership to Advance Next-Generation iPSC-derived Cell Therapies
Monday, June 08, 2026
Made Scientific and Pluristyx announced a strategic partnership to integrate Pluristyx Technology including GMP iPSC lines and derivative cell types, ... read more
Ardena Names Chief Scientific Officer
Monday, June 08, 2026
Ardena announced the appointment of Ariane de Ganck, PhD, as Chief Scientific Officer. read more
SGS Expands Bioanalytical Testing Capabilities in North America with Acquisition of CMIC, INC.
Thursday, June 04, 2026
SGS announced that it has acquired CMIC, INC., a specialized provider of bioanalytical testing services based in Chicago, Illinois. read more